Showing 35,658 results

Filters
How HIV works

HIV-Infected Cells Recirculate Throughout Organs During Suppressive ART

Editor's pick
NATAP
24 February 2022
HIV in the arts & media

‘Three Months’ Review: Troye Sivan in a Refreshing Film About H.I.V.

Editor's pick
The New York Times
24 February 2022
Epidemiology

Most Large HIV Molecular Clusters in US Primarily Involve MSM

Editor's pick
NATAP
24 February 2022
PrEP science

Long-acting doravirine implants as PrEP to prevent vaginal HIV transmission in mouse study

Editor's pick
i-Base
24 February 2022
Dating, relationships & feelings

Centering Sexual Satisfaction in the PrEP Conversation

Editor's pick
POZ
24 February 2022
Drug interactions & pharmacokinetics

No Interactions Between Hormone Therapy and PrEP in Transgender Women or Men

Editor's pick
NATAP
24 February 2022
TB transmission & prevention

Finally Cause for Optimism About TB Vaccine Research, Says Fauci

Editor's pick
Health Policy Watch
23 February 2022
Condoms & lubricant

F.D.A. Grants the First Condom Approval for Anal Sex

Editor's pick
The New York Times
23 February 2022
People & personal stories

Paul Farmer, Pioneer of Global Health, Dies at 62

Editor's pick
The New York Times
23 February 2022

CROI 2022: Ulteriori evidenze a favore del reimpiego del tenofovir nel trattamento di seconda linea, Mercoledì 23 febbraio 2022

February 2022

CROI 2022: Más pruebas que respaldan la reutilización de tenofovir en tratamientos de segunda línea, Miércoles, 23 de febrero de 2022

February 2022

CROI 2022: Des données supplémentaires justifient le recyclage du ténofovir en traitement de deuxième intention, Mercredi 23 février 2022

February 2022

CROI 2022: Mais evidências apoiam a reutilização do tenofovir no tratamento de segunda linha, Quarta-feira, 23 de fevereiro de 2022

February 2022
How HIV works

COVID-19 genetic risk variant protects against HIV

Editor's pick
EurekAlert
23 February 2022
Injectable & long-acting PrEP

Start planning HIV prevention injection rollout, South African experts say

Editor's pick
Spotlight
23 February 2022
Migrants, refugees & displaced people

New report on tuberculosis, HIV and viral hepatitis services for refugees and migrants across the WHO European Region

Editor's pick
World Health Organization
23 February 2022
Finance & funding

Increase funding or abandon hope of ending malaria, TB and Aids, UK warned

Editor's pick
The Guardian
23 February 2022
Antibody-based treatment

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

News
23 February 2022

CROI 2022: More evidence to support recycling tenofovir in second-line treatment, Wednesday 23 February 2022

February 2022

КРОИ 2022: Больше данных в поддержку реутилизации тенофовира в схемах второго выбора, Среда, 23 февраля 2022 г.

February 2022
Global health initiatives

Five African Presidents Launch Global Fund's US$18 Billion Campaign to Restore Progress Against AIDS, TB and Malaria Amid COVID-19 Disruption

Editor's pick
The Global Fund
23 February 2022
The search for an HIV prevention vaccine

Why did an HIV vaccine fail in the Imbokodo trial?

News
23 February 2022
New & experimental HIV treatments

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV

News
23 February 2022
Injectable & long-acting PrEP

Injected PrEP: breakthrough cases could have been detected sooner

News
22 February 2022